Cumulative score based on preoperative plasma fibrinogen and serum C-reactive protein could predict long-term survival for esophageal squamous cell carcinoma

The present study was to establish a prognostic indicator based on preoperative fibrinogen and C-reactive protein (CRP) (FC score) in esophageal squamous cell carcinoma (ESCC). Clinicopathologic characteristics, preoperative plasma fibrinogen and serum CRP levels were reviewed in patients who underw...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncotarget 2016-09, Vol.7 (38), p.61533-61543
Hauptverfasser: Tian, Rui, Yan, Hong, Zhang, Fei, Sun, Peng, Wu, Ai-Ran, Zhang, Min, Jiang, Yu-Lu, Wu, Jing, Lu, Yan-Hong, Xu, Qiu-Yan, Zhan, Xiao-Hong, Zhang, Rong-Xin, Qian, Li-Ting, He, Jie
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 61543
container_issue 38
container_start_page 61533
container_title Oncotarget
container_volume 7
creator Tian, Rui
Yan, Hong
Zhang, Fei
Sun, Peng
Wu, Ai-Ran
Zhang, Min
Jiang, Yu-Lu
Wu, Jing
Lu, Yan-Hong
Xu, Qiu-Yan
Zhan, Xiao-Hong
Zhang, Rong-Xin
Qian, Li-Ting
He, Jie
description The present study was to establish a prognostic indicator based on preoperative fibrinogen and C-reactive protein (CRP) (FC score) in esophageal squamous cell carcinoma (ESCC). Clinicopathologic characteristics, preoperative plasma fibrinogen and serum CRP levels were reviewed in patients who underwent transthoracic esophagectomy. The optimal cut-off value for fibrinogen and CRP was defined as 4.0 g/dL and 10.0 mg/L according to previous reports. Patients with elevated fibrinogen and CRP levels were assigned a score of 2, those with only one of these two abnormalities were allocated a score of 1, and those with neither of the two abnormalities were assigned a score of 0. Preoperative FC score was significantly correlated with degree of differentiation, depth of invasion, tumor-node-metastasis (TNM) stage and modified Glasgow Prognostic Score (mGPS). No significant differences in age, gender, tumor length, tumor location, lymph node status or smoking were identified between groups. Univariate survival analysis demonstrated that high preoperative FC score (1/2) was significantly associated with impaired disease free survival (DFS) [hazard ratio (HR), 1.650; 95% confidence interval (CI), 1.181-2.303; P=0.003] and overall survival (OS) (HR, 1.879; 95% CI, 1.333-2.648; P
doi_str_mv 10.18632/oncotarget.11145
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5308670</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1854801309</sourcerecordid><originalsourceid>FETCH-LOGICAL-c422t-2c8f3258a6c175e539518f46880d508720a514b02c4cab6f5e96a8e6b21dddbe3</originalsourceid><addsrcrecordid>eNpVUctu1TAQtRCIVqUfwAZ5ySbFduzE2SChK15SJTawtibOJDXyI7WdK_Ex_CtpbyllNjOjOXPOjA4hrzm74rprxbsUbaqQF6xXnHOpnpFzPsihEUq1z5_UZ-SylJ9sDyV7LYaX5Ez0ivdy6M_J78MWNg_VHZEWmzLSEQpONEW6Zkwr5tNs9VAC0NmN2cW0YKQQJ1owb4EemoxgT7CcKrpIbdr8dMcwOVupT3FpKuZAy5aP7giezilTLGm9gQX3ttxuENJWqEXvqYVsd5UAr8iLGXzBy4d8QX58-vj98KW5_vb56-HDdWOlELURVs-tUBo6y3uFqh0U17PstGaTYroXDBSXIxNWWhi7WeHQgcZuFHyaphHbC_L-xLtuY8DJYqwZvFmzC5B_mQTO_D-J7sYs6WhUy3TXs53g7QNBTrcblmqCK3e_QMT9LcO1kprxlg07lJ-gNqdSMs6PMpyZe2fNP2fNvbP7zpun9z1u_PWx_QMdS6eU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1854801309</pqid></control><display><type>article</type><title>Cumulative score based on preoperative plasma fibrinogen and serum C-reactive protein could predict long-term survival for esophageal squamous cell carcinoma</title><source>MEDLINE</source><source>PubMed Central Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Free E- Journals</source><creator>Tian, Rui ; Yan, Hong ; Zhang, Fei ; Sun, Peng ; Wu, Ai-Ran ; Zhang, Min ; Jiang, Yu-Lu ; Wu, Jing ; Lu, Yan-Hong ; Xu, Qiu-Yan ; Zhan, Xiao-Hong ; Zhang, Rong-Xin ; Qian, Li-Ting ; He, Jie</creator><creatorcontrib>Tian, Rui ; Yan, Hong ; Zhang, Fei ; Sun, Peng ; Wu, Ai-Ran ; Zhang, Min ; Jiang, Yu-Lu ; Wu, Jing ; Lu, Yan-Hong ; Xu, Qiu-Yan ; Zhan, Xiao-Hong ; Zhang, Rong-Xin ; Qian, Li-Ting ; He, Jie</creatorcontrib><description>The present study was to establish a prognostic indicator based on preoperative fibrinogen and C-reactive protein (CRP) (FC score) in esophageal squamous cell carcinoma (ESCC). Clinicopathologic characteristics, preoperative plasma fibrinogen and serum CRP levels were reviewed in patients who underwent transthoracic esophagectomy. The optimal cut-off value for fibrinogen and CRP was defined as 4.0 g/dL and 10.0 mg/L according to previous reports. Patients with elevated fibrinogen and CRP levels were assigned a score of 2, those with only one of these two abnormalities were allocated a score of 1, and those with neither of the two abnormalities were assigned a score of 0. Preoperative FC score was significantly correlated with degree of differentiation, depth of invasion, tumor-node-metastasis (TNM) stage and modified Glasgow Prognostic Score (mGPS). No significant differences in age, gender, tumor length, tumor location, lymph node status or smoking were identified between groups. Univariate survival analysis demonstrated that high preoperative FC score (1/2) was significantly associated with impaired disease free survival (DFS) [hazard ratio (HR), 1.650; 95% confidence interval (CI), 1.181-2.303; P=0.003] and overall survival (OS) (HR, 1.879; 95% CI, 1.333-2.648; P&lt;0.001), and it remained an independent predictor for both DFS (HR, 1.468; 95% CI, 1.043-2.067; P=0.028) and OS (HR, 2.070; 95% CI, 1.266-3.385; P=0.004) in multivariate Cox regression analysis. Preoperative FC score might represent a new potential marker of worst prognosis that warrants further evaluation in prospective and large cohort studies among ESCC patients who underwent transthoracic esophagectomy.</description><identifier>ISSN: 1949-2553</identifier><identifier>EISSN: 1949-2553</identifier><identifier>DOI: 10.18632/oncotarget.11145</identifier><identifier>PMID: 27517497</identifier><language>eng</language><publisher>United States: Impact Journals LLC</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Biomarkers, Tumor - blood ; C-Reactive Protein - analysis ; Carcinoma, Squamous Cell - blood ; Carcinoma, Squamous Cell - mortality ; Carcinoma, Squamous Cell - surgery ; Disease-Free Survival ; Esophageal Neoplasms - blood ; Esophageal Neoplasms - mortality ; Esophageal Neoplasms - surgery ; Esophageal Squamous Cell Carcinoma ; Esophagectomy - methods ; Female ; Fibrinogen - analysis ; Follow-Up Studies ; Humans ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Predictive Value of Tests ; Preoperative Period ; Prognosis ; Proportional Hazards Models ; Prospective Studies ; Research Paper ; Retrospective Studies ; Young Adult</subject><ispartof>Oncotarget, 2016-09, Vol.7 (38), p.61533-61543</ispartof><rights>Copyright: © 2016 Tian et al. 2016</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c422t-2c8f3258a6c175e539518f46880d508720a514b02c4cab6f5e96a8e6b21dddbe3</citedby><cites>FETCH-LOGICAL-c422t-2c8f3258a6c175e539518f46880d508720a514b02c4cab6f5e96a8e6b21dddbe3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5308670/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5308670/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27517497$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tian, Rui</creatorcontrib><creatorcontrib>Yan, Hong</creatorcontrib><creatorcontrib>Zhang, Fei</creatorcontrib><creatorcontrib>Sun, Peng</creatorcontrib><creatorcontrib>Wu, Ai-Ran</creatorcontrib><creatorcontrib>Zhang, Min</creatorcontrib><creatorcontrib>Jiang, Yu-Lu</creatorcontrib><creatorcontrib>Wu, Jing</creatorcontrib><creatorcontrib>Lu, Yan-Hong</creatorcontrib><creatorcontrib>Xu, Qiu-Yan</creatorcontrib><creatorcontrib>Zhan, Xiao-Hong</creatorcontrib><creatorcontrib>Zhang, Rong-Xin</creatorcontrib><creatorcontrib>Qian, Li-Ting</creatorcontrib><creatorcontrib>He, Jie</creatorcontrib><title>Cumulative score based on preoperative plasma fibrinogen and serum C-reactive protein could predict long-term survival for esophageal squamous cell carcinoma</title><title>Oncotarget</title><addtitle>Oncotarget</addtitle><description>The present study was to establish a prognostic indicator based on preoperative fibrinogen and C-reactive protein (CRP) (FC score) in esophageal squamous cell carcinoma (ESCC). Clinicopathologic characteristics, preoperative plasma fibrinogen and serum CRP levels were reviewed in patients who underwent transthoracic esophagectomy. The optimal cut-off value for fibrinogen and CRP was defined as 4.0 g/dL and 10.0 mg/L according to previous reports. Patients with elevated fibrinogen and CRP levels were assigned a score of 2, those with only one of these two abnormalities were allocated a score of 1, and those with neither of the two abnormalities were assigned a score of 0. Preoperative FC score was significantly correlated with degree of differentiation, depth of invasion, tumor-node-metastasis (TNM) stage and modified Glasgow Prognostic Score (mGPS). No significant differences in age, gender, tumor length, tumor location, lymph node status or smoking were identified between groups. Univariate survival analysis demonstrated that high preoperative FC score (1/2) was significantly associated with impaired disease free survival (DFS) [hazard ratio (HR), 1.650; 95% confidence interval (CI), 1.181-2.303; P=0.003] and overall survival (OS) (HR, 1.879; 95% CI, 1.333-2.648; P&lt;0.001), and it remained an independent predictor for both DFS (HR, 1.468; 95% CI, 1.043-2.067; P=0.028) and OS (HR, 2.070; 95% CI, 1.266-3.385; P=0.004) in multivariate Cox regression analysis. Preoperative FC score might represent a new potential marker of worst prognosis that warrants further evaluation in prospective and large cohort studies among ESCC patients who underwent transthoracic esophagectomy.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biomarkers, Tumor - blood</subject><subject>C-Reactive Protein - analysis</subject><subject>Carcinoma, Squamous Cell - blood</subject><subject>Carcinoma, Squamous Cell - mortality</subject><subject>Carcinoma, Squamous Cell - surgery</subject><subject>Disease-Free Survival</subject><subject>Esophageal Neoplasms - blood</subject><subject>Esophageal Neoplasms - mortality</subject><subject>Esophageal Neoplasms - surgery</subject><subject>Esophageal Squamous Cell Carcinoma</subject><subject>Esophagectomy - methods</subject><subject>Female</subject><subject>Fibrinogen - analysis</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Kaplan-Meier Estimate</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Predictive Value of Tests</subject><subject>Preoperative Period</subject><subject>Prognosis</subject><subject>Proportional Hazards Models</subject><subject>Prospective Studies</subject><subject>Research Paper</subject><subject>Retrospective Studies</subject><subject>Young Adult</subject><issn>1949-2553</issn><issn>1949-2553</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVUctu1TAQtRCIVqUfwAZ5ySbFduzE2SChK15SJTawtibOJDXyI7WdK_Ex_CtpbyllNjOjOXPOjA4hrzm74rprxbsUbaqQF6xXnHOpnpFzPsihEUq1z5_UZ-SylJ9sDyV7LYaX5Ez0ivdy6M_J78MWNg_VHZEWmzLSEQpONEW6Zkwr5tNs9VAC0NmN2cW0YKQQJ1owb4EemoxgT7CcKrpIbdr8dMcwOVupT3FpKuZAy5aP7giezilTLGm9gQX3ttxuENJWqEXvqYVsd5UAr8iLGXzBy4d8QX58-vj98KW5_vb56-HDdWOlELURVs-tUBo6y3uFqh0U17PstGaTYroXDBSXIxNWWhi7WeHQgcZuFHyaphHbC_L-xLtuY8DJYqwZvFmzC5B_mQTO_D-J7sYs6WhUy3TXs53g7QNBTrcblmqCK3e_QMT9LcO1kprxlg07lJ-gNqdSMs6PMpyZe2fNP2fNvbP7zpun9z1u_PWx_QMdS6eU</recordid><startdate>20160920</startdate><enddate>20160920</enddate><creator>Tian, Rui</creator><creator>Yan, Hong</creator><creator>Zhang, Fei</creator><creator>Sun, Peng</creator><creator>Wu, Ai-Ran</creator><creator>Zhang, Min</creator><creator>Jiang, Yu-Lu</creator><creator>Wu, Jing</creator><creator>Lu, Yan-Hong</creator><creator>Xu, Qiu-Yan</creator><creator>Zhan, Xiao-Hong</creator><creator>Zhang, Rong-Xin</creator><creator>Qian, Li-Ting</creator><creator>He, Jie</creator><general>Impact Journals LLC</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20160920</creationdate><title>Cumulative score based on preoperative plasma fibrinogen and serum C-reactive protein could predict long-term survival for esophageal squamous cell carcinoma</title><author>Tian, Rui ; Yan, Hong ; Zhang, Fei ; Sun, Peng ; Wu, Ai-Ran ; Zhang, Min ; Jiang, Yu-Lu ; Wu, Jing ; Lu, Yan-Hong ; Xu, Qiu-Yan ; Zhan, Xiao-Hong ; Zhang, Rong-Xin ; Qian, Li-Ting ; He, Jie</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c422t-2c8f3258a6c175e539518f46880d508720a514b02c4cab6f5e96a8e6b21dddbe3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biomarkers, Tumor - blood</topic><topic>C-Reactive Protein - analysis</topic><topic>Carcinoma, Squamous Cell - blood</topic><topic>Carcinoma, Squamous Cell - mortality</topic><topic>Carcinoma, Squamous Cell - surgery</topic><topic>Disease-Free Survival</topic><topic>Esophageal Neoplasms - blood</topic><topic>Esophageal Neoplasms - mortality</topic><topic>Esophageal Neoplasms - surgery</topic><topic>Esophageal Squamous Cell Carcinoma</topic><topic>Esophagectomy - methods</topic><topic>Female</topic><topic>Fibrinogen - analysis</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Kaplan-Meier Estimate</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Predictive Value of Tests</topic><topic>Preoperative Period</topic><topic>Prognosis</topic><topic>Proportional Hazards Models</topic><topic>Prospective Studies</topic><topic>Research Paper</topic><topic>Retrospective Studies</topic><topic>Young Adult</topic><toplevel>online_resources</toplevel><creatorcontrib>Tian, Rui</creatorcontrib><creatorcontrib>Yan, Hong</creatorcontrib><creatorcontrib>Zhang, Fei</creatorcontrib><creatorcontrib>Sun, Peng</creatorcontrib><creatorcontrib>Wu, Ai-Ran</creatorcontrib><creatorcontrib>Zhang, Min</creatorcontrib><creatorcontrib>Jiang, Yu-Lu</creatorcontrib><creatorcontrib>Wu, Jing</creatorcontrib><creatorcontrib>Lu, Yan-Hong</creatorcontrib><creatorcontrib>Xu, Qiu-Yan</creatorcontrib><creatorcontrib>Zhan, Xiao-Hong</creatorcontrib><creatorcontrib>Zhang, Rong-Xin</creatorcontrib><creatorcontrib>Qian, Li-Ting</creatorcontrib><creatorcontrib>He, Jie</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Oncotarget</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tian, Rui</au><au>Yan, Hong</au><au>Zhang, Fei</au><au>Sun, Peng</au><au>Wu, Ai-Ran</au><au>Zhang, Min</au><au>Jiang, Yu-Lu</au><au>Wu, Jing</au><au>Lu, Yan-Hong</au><au>Xu, Qiu-Yan</au><au>Zhan, Xiao-Hong</au><au>Zhang, Rong-Xin</au><au>Qian, Li-Ting</au><au>He, Jie</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cumulative score based on preoperative plasma fibrinogen and serum C-reactive protein could predict long-term survival for esophageal squamous cell carcinoma</atitle><jtitle>Oncotarget</jtitle><addtitle>Oncotarget</addtitle><date>2016-09-20</date><risdate>2016</risdate><volume>7</volume><issue>38</issue><spage>61533</spage><epage>61543</epage><pages>61533-61543</pages><issn>1949-2553</issn><eissn>1949-2553</eissn><abstract>The present study was to establish a prognostic indicator based on preoperative fibrinogen and C-reactive protein (CRP) (FC score) in esophageal squamous cell carcinoma (ESCC). Clinicopathologic characteristics, preoperative plasma fibrinogen and serum CRP levels were reviewed in patients who underwent transthoracic esophagectomy. The optimal cut-off value for fibrinogen and CRP was defined as 4.0 g/dL and 10.0 mg/L according to previous reports. Patients with elevated fibrinogen and CRP levels were assigned a score of 2, those with only one of these two abnormalities were allocated a score of 1, and those with neither of the two abnormalities were assigned a score of 0. Preoperative FC score was significantly correlated with degree of differentiation, depth of invasion, tumor-node-metastasis (TNM) stage and modified Glasgow Prognostic Score (mGPS). No significant differences in age, gender, tumor length, tumor location, lymph node status or smoking were identified between groups. Univariate survival analysis demonstrated that high preoperative FC score (1/2) was significantly associated with impaired disease free survival (DFS) [hazard ratio (HR), 1.650; 95% confidence interval (CI), 1.181-2.303; P=0.003] and overall survival (OS) (HR, 1.879; 95% CI, 1.333-2.648; P&lt;0.001), and it remained an independent predictor for both DFS (HR, 1.468; 95% CI, 1.043-2.067; P=0.028) and OS (HR, 2.070; 95% CI, 1.266-3.385; P=0.004) in multivariate Cox regression analysis. Preoperative FC score might represent a new potential marker of worst prognosis that warrants further evaluation in prospective and large cohort studies among ESCC patients who underwent transthoracic esophagectomy.</abstract><cop>United States</cop><pub>Impact Journals LLC</pub><pmid>27517497</pmid><doi>10.18632/oncotarget.11145</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1949-2553
ispartof Oncotarget, 2016-09, Vol.7 (38), p.61533-61543
issn 1949-2553
1949-2553
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5308670
source MEDLINE; PubMed Central Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central; Free E- Journals
subjects Adult
Aged
Aged, 80 and over
Biomarkers, Tumor - blood
C-Reactive Protein - analysis
Carcinoma, Squamous Cell - blood
Carcinoma, Squamous Cell - mortality
Carcinoma, Squamous Cell - surgery
Disease-Free Survival
Esophageal Neoplasms - blood
Esophageal Neoplasms - mortality
Esophageal Neoplasms - surgery
Esophageal Squamous Cell Carcinoma
Esophagectomy - methods
Female
Fibrinogen - analysis
Follow-Up Studies
Humans
Kaplan-Meier Estimate
Male
Middle Aged
Predictive Value of Tests
Preoperative Period
Prognosis
Proportional Hazards Models
Prospective Studies
Research Paper
Retrospective Studies
Young Adult
title Cumulative score based on preoperative plasma fibrinogen and serum C-reactive protein could predict long-term survival for esophageal squamous cell carcinoma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T10%3A37%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cumulative%20score%20based%20on%20preoperative%20plasma%20fibrinogen%20and%20serum%20C-reactive%20protein%20could%20predict%20long-term%20survival%20for%20esophageal%20squamous%20cell%20carcinoma&rft.jtitle=Oncotarget&rft.au=Tian,%20Rui&rft.date=2016-09-20&rft.volume=7&rft.issue=38&rft.spage=61533&rft.epage=61543&rft.pages=61533-61543&rft.issn=1949-2553&rft.eissn=1949-2553&rft_id=info:doi/10.18632/oncotarget.11145&rft_dat=%3Cproquest_pubme%3E1854801309%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1854801309&rft_id=info:pmid/27517497&rfr_iscdi=true